You just read:

FDA Grants Fast Track Designation to Bayer's Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone

News provided by

Bayer HealthCare Pharmaceuticals, Inc.

Aug 23, 2011, 02:00 ET